# The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.

> **NCT04248179** · PHASE4 · COMPLETED · sponsor: **Zealand University Hospital** · enrollment: 36 (actual)

## Conditions studied

- Breast Cancer
- Ductal Carcinoma in Situ

## Interventions

- **DRUG:** Ropivacaine injection
- **DRUG:** Saline 0.9%
- **DRUG:** Sufentanil and PONV prophylaxis

## Key facts

- **NCT ID:** NCT04248179
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-29
- **Primary completion:** 2021-12-08
- **Final completion:** 2021-12-08
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04248179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04248179, "The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04248179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*